Instalab
logoInstalab

Arthritis Panel

Blood Test
See whether your aching joints trace back to inflammation, an autoimmune process, or gout, instead of guessing from one number.
4.9 (2,576 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Arthritis Panel test?

This test is most useful if any of these apply to you.

Waking Up With Stiff, Swollen Joints
You have morning stiffness or swelling that lingers, and you want to know if inflammation or an autoimmune process is behind it.
Getting Sudden, Severe Joint Attacks
You get abrupt, intense pain in a single joint like the big toe and want to check whether uric acid points toward gout.
Autoimmune Disease Runs in Your Family
You have relatives with lupus or rheumatoid arthritis and want an early read on whether your own immune system is involved.
Joint Pain Nobody Can Explain
Your aching joints have gone undiagnosed, and you want a structured starting point that separates inflammatory from ordinary causes.

5 biomarkers included

About Arthritis Panel

Joint pain is easy to notice and hard to explain. The same swollen, stiff, or throbbing joint can come from an autoimmune disease, a crystal buildup, or ordinary wear on cartilage, and the treatments for each are completely different.

This panel measures five blood markers in a single draw to map those possibilities at once. No one result settles the question. The value lives in the pattern the five make together.

What This Panel Reveals

A joint can hurt for reasons that sit on very different biological axes, and this panel probes three of them. It reads how much inflammation is active, whether your immune system is attacking your own tissue, and whether a metabolic waste product is crystallizing in your joints.

The inflammation axis comes from two markers. One is a protein your liver pumps out within hours of an inflammatory trigger (called C-reactive protein, or CRP). The other measures how fast red blood cells settle in a tube (the erythrocyte sedimentation rate, or ESR), which tracks inflammation that builds and fades more slowly. Reading both catches active inflammation that either one alone can miss.

The autoimmune axis comes from two antibody tests. Rheumatoid factor (RF) is an antibody that targets your own antibodies, and its presence leans toward rheumatoid arthritis, a disease where the immune system attacks the joint lining. The antinuclear antibody screen (ANA) detects antibodies aimed at the center of your own cells, which points toward systemic autoimmune conditions such as lupus.

The metabolic axis is uric acid, a waste product that can form needle-like crystals in joints when it climbs too high. It captures the gout question that neither the inflammation nor the autoimmune markers can answer. Crystals tend to form once uric acid passes its solubility point, roughly 6.8 mg/dL.

How to Read Your Results Together

The panel is most useful when you stop reading one line at a time and look at which axes light up together. A few patterns cover most of what people see.

PatternWhat It Suggests
RF positive with high CRP and ESRAn inflammatory, autoimmune picture. Rheumatoid arthritis moves up the list. A follow-up anti-CCP antibody test sharpens this considerably.
ANA positive with normal CRP and ESRPoints toward systemic autoimmunity such as lupus more than rheumatoid arthritis. The titer and pattern of the ANA matter here.
High uric acid with a hot, sudden joint attackFits gout. Note that uric acid can read normal during the actual attack, so a normal value does not clear it.
All five markers normal despite real painLeans toward a non-inflammatory cause such as osteoarthritis, the wear-and-tear form of joint disease.

The discordant results are where this panel earns its place. Uric acid often dips during a gout flare rather than spiking. In one study, average levels were lower during the attack than two weeks later, 464 versus 527 micromoles per liter, and across studies a normal reading during a flare shows up in anywhere from roughly 1 in 7 to nearly half of people, depending on the cutoff used.

The autoantibody tests cut both ways too. A positive ANA is common in people with no disease at all, with general-population positivity reported at roughly 10% to 30% depending on the assay and cutoff used, so a lone positive without symptoms is usually not lupus. And normal inflammation markers do not clear you either. All three of ESR, CRP, and RF were normal at diagnosis in roughly 14% to 15% of rheumatoid arthritis patients in one large analysis.

What to Do with Your Results

Any pattern pointing toward inflammatory or autoimmune disease is worth a rheumatologist's eye, not watchful waiting. If RF is positive with raised inflammation markers, an anti-CCP antibody test adds specificity that RF alone lacks. If ANA is positive, follow-up antibody panels and complement levels help separate lupus from a harmless positive. If a joint attack looks like gout, the definitive step is examining fluid from the joint for crystals or imaging it, since blood uric acid supports the diagnosis rather than proving it.

Serial tracking matters most for the inflammation markers, which rise and fall with disease activity and response to treatment. If you are actively managing a diagnosed inflammatory arthritis, retesting every 3 to 6 months shows whether the process is quieting. For uric acid, a value drawn away from an active flare gives the truest read of your baseline.

When Results Can Be Misleading

Several confounders move more than one marker at once. A recent infection or any acute illness can push CRP and ESR up and can transiently raise RF and ANA, mimicking an autoimmune flare. This is why these markers are read alongside your symptoms and exam, not in isolation, and why a single surprising result is often worth repeating before acting on it.

Frequently Asked Questions

References

8 studies
  1. Daniel Aletaha, Tuhina Neogi, Alan J. Silman, Julia Funovits, David T. FelsonAnnals of the Rheumatic Diseases2010
  2. Francesca Motta, Nicola Bizzaro, Davide Giavarina, Franco Franceschini, Carlo SelmiRMD Open2023
  3. Johan Rönnelid, Carl Turesson, Alf KastbomFrontiers in Immunology2021
  4. Marcelina Kądziela, Aleksandra Fijałkowska, Marzena Kraska-gacka, Anna WoźniackaJournal of Clinical Medicine2025